Retatrutide 5mg

Description

Retatrutide 5 mg Vial with 2 ml Bacteriostatic Water

Retatrutide is a next-generation multi-agonist peptide designed to target three key metabolic pathways simultaneously: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. This triple-action mechanism offers powerful support for weight loss, improved metabolic health, and potential benefits in blood sugar regulation.

Benefits
Retatrutide works by reducing appetite, slowing gastric emptying, enhancing insulin sensitivity, and increasing energy expenditure. Many users experience reduced cravings, improved satiety, and a steady, sustainable reduction in body fat.

Format
Each vial contains 5 mg of lyophilised Retatrutide peptide, supplied with a 2 ml bacteriostatic water ampule for reconstitution. Once reconstituted, the solution is administered via subcutaneous injection.

Suggested Use
Typical starting dose for weight management is 2mg once per week, gradually increasing based on tolerance and desired effect. Dosage should always be adjusted under the guidance of a qualified healthcare provider.